WhichRecall
Class IIReported 2026-01-07

Ondansetron Orally Disintegrating Tablets, USP, 4mg, 30 Tablets (3 blistercards each containing 10 tablets), Rx only, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, Product of India, NDC 68462-157-13

Recalled by Glenmark Pharmaceuticals Inc., USA

Reason for Recall

Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out

Advertisement

Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.

Recall Number
D-0246-2026
Classification
Class II
Status
Ongoing
Category
drug
Initiated
2025-12-30
Reported
2026-01-07
Distribution
Nationwide within the United States
Code Info
Lot #: 19251311, Exp Date April 2027
Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.
Advertisement